Case Report
PDF Zotero Mendeley EndNote BibTex Cite

Geriatrik hastada COVID-19 ilişkili akut hepatit olgusu

Year 2021, Volume 2, Issue 3, 102 - 104, 08.09.2021
https://doi.org/10.47582/jompac.886900

Abstract

Koronavirüs 2019 hastalığı (COVID-19) dünya genelinde 44 milyon pozitif vaka ve 1 milyonun üzerine ölüme sebep olan ölümcül bir hastalıktır. COVID-19 ateş, nefes darlığı ve öksürük gibi solunum yolu enfeksiyon hastalıkları bulgularının daha sık izlendiği bir hastalıktır. Solunumsal semptomlarının yanında literatür çalışmalarında karaciğer hasarına yol açtığı görülmüştür. Vakamız 77 yaşında erkek, hipertansiyon haricinde herhangi bir sistemik hastalığı yoktu. Dört gündür başlayan 38,2°C ateş, nabız 84/dk, solunum sayısı 18/dk, tansiyon 136/82 mmHg, oda havasında oksigen saturasyonu pulse oksimetri ile ölçümü %92’idi. Acil servisteki tetkiklerinde aspartat aminotransferaz (AST) 753 IU/L ve alanin aminotransferaz (ALT) 683 U/l olan hastanın akut karaciğer hasarı olması, acil serviste yapılan COVID-19 PCR-RT testinde pozitif olması nedeniyle enfeksiyon hastalıkları servisine yatırıldı. Vakamızda karaciğer enzim yüksekliği yapan diğer nedenler dışlandıktan sonra COVID-19 ilişkili akut hepatit olgusu tanısı konuldu. Olgumuzu literatüre sunarak katkı sağlamayı amaçladık.

References

  • Johns Hopkins coronavirus resource center retrieved from https://coronavirus.jhu.edu/data/mortality at 08.02 pm. 28.10.2020.
  • Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Actualización en COVID-19 y enfermedad hepática. Gastroenterol Hepatol 2020; 43: 472-80.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
  • Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020; 40: 998-1004.
  • Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020; 251: 228-48.
  • Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol 2020; 8: 18-24.
  • Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis. Front Med (Lausanne) 2020; 7: 431.
  • Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020; 33: 1007-14.
  • Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004; 39: 302-10.
  • Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology 2018; 72: 516-24.
  • Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol 2020; 115: 941-2.
  • Lagana SM, De Michele S, Lee MJ, et al. COVID-19 associated hepatitis complicating recent living donor liver transplantation. Arch Pathol Lab Med 2020; 10.5858/arpa.2020-0186-SA.

A case of acute hepatitis associated with COVID-19 in a geriatric patient

Year 2021, Volume 2, Issue 3, 102 - 104, 08.09.2021
https://doi.org/10.47582/jompac.886900

Abstract

Coronavirus 2019 disease (COVID-19) is a deadly disease that causes 44 million positive cases and over 1 million deaths worldwide. COVID-19 is a disease in which respiratory tract infectious diseases such as fever, shortness of breath, and cough are observed more frequently. It has been observed to cause liver damage in literature studies in addition to respiratory symptoms. Our case is a 77-year-old male having no systemic disease except hypertension. Fever of 38.2°C for four days, pulse 84/min, respiratory rate 18/min, blood pressure 136/82 mmHg, and oxygen saturation on room air was measured 92% by pulse oximetry. The patient who had aspartate aminotransferase (AST) 753 IU/L and alanine aminotransferase (ALT) 683 U/L in the tests in the emergency room was admitted to the infectious diseases service because of acute liver damage and the positive result of the COVID-19 PCR-RT test performed in the emergency department. The diagnosis of acute hepatitis associated with COVID-19 was made in our case, after excluding other causes of elevated liver enzymes. We aimed to contribute to the literature by presenting our case.

References

  • Johns Hopkins coronavirus resource center retrieved from https://coronavirus.jhu.edu/data/mortality at 08.02 pm. 28.10.2020.
  • Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Actualización en COVID-19 y enfermedad hepática. Gastroenterol Hepatol 2020; 43: 472-80.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
  • Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020; 40: 998-1004.
  • Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020; 251: 228-48.
  • Feng G, Zheng KI, Yan QQ, et al. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J Clin Transl Hepatol 2020; 8: 18-24.
  • Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. serum activity of liver enzymes is associated with higher mortality in COVID-19: a systematic review and meta-analysis. Front Med (Lausanne) 2020; 7: 431.
  • Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020; 33: 1007-14.
  • Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology 2004; 39: 302-10.
  • Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology 2018; 72: 516-24.
  • Wander P, Epstein M, Bernstein D. COVID-19 presenting as acute hepatitis. Am J Gastroenterol 2020; 115: 941-2.
  • Lagana SM, De Michele S, Lee MJ, et al. COVID-19 associated hepatitis complicating recent living donor liver transplantation. Arch Pathol Lab Med 2020; 10.5858/arpa.2020-0186-SA.

Details

Primary Language English
Subjects Health Care Sciences and Services
Journal Section Case Report [en] Olgu Sunumu [tr]
Authors

Muharrem BAYRAK (Primary Author)
Health Sciences University, Erzurum Regional Training and Research Hospital, Department of Internal Medicine, Erzurum, 25240, Turkey
Türkiye


Kenan ÇADIRCI
Health Sciences University, Erzurum Regional Training and Research Hospital, Department of Internal Medicine, Erzurum, 25240, Turkey
Türkiye

Publication Date September 8, 2021
Published in Issue Year 2021, Volume 2, Issue 3

Cite

Bibtex @case report { jompac886900, journal = {Journal of Medicine and Palliative Care}, issn = {}, eissn = {2717-7505}, address = {Kırıkkale Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı}, publisher = {MediHealth Academy Yayıncılık}, year = {2021}, volume = {2}, pages = {102 - 104}, doi = {10.47582/jompac.886900}, title = {A case of acute hepatitis associated with COVID-19 in a geriatric patient}, key = {cite}, author = {Çadırcı, Kenan} }
APA Bayrak, M. & Çadırcı, K. (2021). A case of acute hepatitis associated with COVID-19 in a geriatric patient . Journal of Medicine and Palliative Care , 2 (3) , 102-104 . DOI: 10.47582/jompac.886900
MLA Bayrak, M. , Çadırcı, K. "A case of acute hepatitis associated with COVID-19 in a geriatric patient" . Journal of Medicine and Palliative Care 2 (2021 ): 102-104 <https://dergipark.org.tr/en/pub/jompac/issue/64841/886900>
Chicago Bayrak, M. , Çadırcı, K. "A case of acute hepatitis associated with COVID-19 in a geriatric patient". Journal of Medicine and Palliative Care 2 (2021 ): 102-104
RIS TY - JOUR T1 - A case of acute hepatitis associated with COVID-19 in a geriatric patient AU - Muharrem Bayrak , Kenan Çadırcı Y1 - 2021 PY - 2021 N1 - doi: 10.47582/jompac.886900 DO - 10.47582/jompac.886900 T2 - Journal of Medicine and Palliative Care JF - Journal JO - JOR SP - 102 EP - 104 VL - 2 IS - 3 SN - -2717-7505 M3 - doi: 10.47582/jompac.886900 UR - https://doi.org/10.47582/jompac.886900 Y2 - 2021 ER -
EndNote %0 Journal of Medicine and Palliative Care A case of acute hepatitis associated with COVID-19 in a geriatric patient %A Muharrem Bayrak , Kenan Çadırcı %T A case of acute hepatitis associated with COVID-19 in a geriatric patient %D 2021 %J Journal of Medicine and Palliative Care %P -2717-7505 %V 2 %N 3 %R doi: 10.47582/jompac.886900 %U 10.47582/jompac.886900
ISNAD Bayrak, Muharrem , Çadırcı, Kenan . "A case of acute hepatitis associated with COVID-19 in a geriatric patient". Journal of Medicine and Palliative Care 2 / 3 (September 2021): 102-104 . https://doi.org/10.47582/jompac.886900
AMA Bayrak M. , Çadırcı K. A case of acute hepatitis associated with COVID-19 in a geriatric patient. J Med Palliat Care / JOMPAC / jompac. 2021; 2(3): 102-104.
Vancouver Bayrak M. , Çadırcı K. A case of acute hepatitis associated with COVID-19 in a geriatric patient. Journal of Medicine and Palliative Care. 2021; 2(3): 102-104.
IEEE M. Bayrak and K. Çadırcı , "A case of acute hepatitis associated with COVID-19 in a geriatric patient", Journal of Medicine and Palliative Care, vol. 2, no. 3, pp. 102-104, Sep. 2021, doi:10.47582/jompac.886900


18592


google-scholar.png

researchgate-vector-logo.png

crossref.jpg

f9ab67f.png

asos-index.png


COPE.jpg

icmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.png



Our journal is in DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index and Turkiye Citation Index.

TR-Dizin, EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

Journal articles are evaluated as "Double-Blind Peer Review". No fees are charged for submitted articles.